4G Clinical, a clinical trials software company focused on simplifying and accelerating the drug development process, said today that it has raised $5 million in Series A1 financing led by Boston-based Schooner Capital. Combined with $2.5 million that was announced in January, this latest round of financing brings 4G's Series A funding total to $7.5 million.